查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1992077

胃鏡市場：全球市場按產品、分銷管道、最終用戶和應用分類的預測，2026-2032年

Gastroscopes Market by Product, Distribution Channel, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年胃鏡市值為 31.7 億美元，預計到 2026 年將成長至 33.8 億美元，複合年成長率為 7.33%，到 2032 年將達到 52.1 億美元。

主要市場統計數據
基準年 2025 31.7億美元
預計年份：2026年 33.8億美元
預測年份 2032 52.1億美元
複合年成長率 (%) 7.33%

對胃腸內視鏡設備當前發展趨勢的權威而簡明的概述，旨在為臨床和商業相關人員的策略決策提供支援。

胃鏡檢查仍然是消化器官系統診斷和治療的基石，其配套設備也在快速發展。門診手術中心、診所和醫院等終端使用者不斷要求更高解析度的影像、更符合人體工學的操作體驗以及能夠縮短檢查時間和降低感染風險的工作流程。同時，製造商也面臨越來越高的期望，即整合數位化功能和售後服務能夠延長其設備使用壽命。

技術進步、採購重點的轉變、對感染預防的監管重點以及影響胃鏡檢查引入的數位化整合，這些因素顯然是相互關聯的。

胃鏡市場環境正處於技術和營運變革的十字路口，這些變革正在重塑臨床路徑和經營模式。高清數位影像技術和影像軟式內視鏡的普及提高了人們對診斷的期望，而一次性耗材和消毒技術的進步正在重塑感染控制通訊協定。同時，用於病變檢測和影像校正的人工智慧工具正從試驗研究走向常規臨床應用，這既提高了手術效率，也改變了臨床醫生的訓練要求。

對 2025 年關稅調整將如何影響胃腸內視鏡供應鏈中的採購經濟性、供應商策略和區域製造決策進行詳細分析。

近期關稅調整迫使全球先進醫療設備及相關耗材供應鏈進行重大重組。進口關稅增加了依賴跨境零件流通的製造商和經銷商的收貨成本，迫使許多機構重新評估其採購地點並實現供應商多元化。因此，醫院和門診的採購團隊越來越重視供應商的韌性、雙重採購以及本地庫存緩衝，以降低交貨風險並保障醫療服務的連續性。

細分市場主導的洞察能夠清楚地展現產品、最終用戶、應用和分銷趨勢，從而製定有針對性的商業性和臨床策略。

細分分析揭示了不同產品類型、終端用戶群體、臨床應用和分銷管道的價值促進因素各不相同。在產品細分中，軟式和硬式胃鏡滿足不同的臨床需求。軟式設備為診斷和治療流程提供了必要的便利性和操作性，而硬式器械則用於特定的手術場景，並具有不同的滅菌和再處理流程。軟式內視鏡本身又可分為光纖技術和視訊技術，其中視訊系統具有更佳的影像品質、數位整合以及更易於整合影像分析工具等優勢。另一方面，硬式內視鏡既可作為可重複使用的平台，最佳化了耐用性和單次使用成本，也可作為一次性產品，降低交叉感染風險並簡化物流。

基於證據的區域比較主要全球市場的臨床引入促進因素、報銷模式和生產趨勢。

臨床實務、報銷框架和製造生態系統的區域差異顯著影響部署模式和策略重點。在美洲，成熟的臨床基礎設施和集中採購網路為高品質影像平台和整合服務合約創造了機遇，同時也推動了對本地製造和組裝的投資，以降低關稅風險並縮短產品上市時間。因此，該地區的相關人員對話通常圍繞著總體擁有成本、與醫院系統的互通性以及支援部署所需的循證依據。

對競爭策略的深入分析，展示了產品創新、服務和通路策略如何重新定義胃鏡市場中的供應商定位。

胃鏡生態系統中的主要企業正透過影像技術、一次性產品策略和服務交付的創新來脫穎而出。許多老牌製造商優先發展高解析度視訊系統和模組化架構，以便在不更換整個平台的情況下進行臨床升級。同時，許多新興企業則專注於一次性胃鏡和混合服務模式，以解決感染控制問題，並減輕消毒能力有限的醫療機構的再處理負擔。

為製造商、醫療保健提供者和通路合作夥伴提供切實可行的策略建議，將結構性變革轉化為永續的競爭優勢。

產業領導企業可以透過調整產品藍圖，使其與臨床工作流程和採購實際情況相契合，從而將市場複雜性轉化為競爭優勢。製造商應互通性，以便在分階段升級產品時融入先進的影像處理和人工智慧功能，同時保障客戶的投資。此外，投資可靠的臨床證據並追蹤真實世界的結果，可以實際展現診斷準確性和手術效率的提升，從而加速產品的普及應用。

為了支持研究結果，我們採用了嚴格的混合方法研究框架，結合了對主要相關人員的訪談、對監管和臨床證據的審查以及供應鏈分析。

本研究採用混合方法，結合與關鍵相關人員的對話和對二手證據的三角檢驗，以確保得出可靠且可重複的結論。對臨床負責人、採購專家、設備工程師和分銷主管的結構化訪談是主要資訊來源，並輔以諮詢委員會，該委員會負責檢驗新的主題和營運重點。這些努力提供了關於影響臨床工作流程、決策標準和採購週期的實際限制的真實背景。

對策略挑戰和麵向未來的優先事項進行簡潔整合，明確界定了通往更安全、更有效率的胃鏡解決方案的路徑。

總而言之，胃鏡市場在臨床方面較為保守，但在商業性和技術方面卻瞬息萬變。對診斷清晰度、感染控制以及不斷變化的採購優先事項的需求，正在重塑產品設計、分銷和服務模式。目前的策略性應對措施主要圍繞著整合先進的影像處理和數據功能、提供靈活的商業條款以及增強供應鏈抵禦關稅和貿易不確定性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：胃鏡市場：依產品分類

  • 靈活的
    • 光纖
    • 影片
  • 硬度
    • 可重複使用的
    • 一次性的

第9章：胃鏡市場：依通路分類

  • 離線
  • 線上

第10章：胃鏡市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第11章：胃鏡市場：依應用領域分類

  • 複雜類型
  • 用於診斷
  • 治療

第12章：胃鏡市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：胃鏡市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：胃鏡市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國胃鏡市場

第16章：中國胃鏡市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • Ankon Medical Technologies Co., Ltd.
  • Aohua Endoscopy Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • Ethicon
  • Fujifilm Holdings Corporation
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Olympus Corporation
  • PENTAX Medical
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • SonoScape Medical Corp.
  • Stryker Corporation
Product Code: MRR-20543276F0ED

The Gastroscopes Market was valued at USD 3.17 billion in 2025 and is projected to grow to USD 3.38 billion in 2026, with a CAGR of 7.33%, reaching USD 5.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.17 billion
Estimated Year [2026] USD 3.38 billion
Forecast Year [2032] USD 5.21 billion
CAGR (%) 7.33%

An authoritative and concise orientation to current gastroscopy device dynamics that primes strategic decision-making across clinical and commercial stakeholders

Gastroscopy remains a cornerstone of gastrointestinal diagnostics and interventions, and the device ecosystem that supports it is undergoing rapid evolution. End users across ambulatory surgical centers, clinics, and hospitals continue to demand higher image fidelity, enhanced ergonomics, and workflows that reduce procedure time and infection risk. At the same time, manufacturers face rising expectations for integrated digital capabilities and post-sale support that extend the lifetime value of capital equipment.

This executive summary synthesizes contemporary technology trends, regulatory pressures, supply chain dynamics, and segmentation behavior that together shape procurement decisions and clinical adoption. It seeks to equip executives, clinical leaders, and supply chain managers with a clear, actionable understanding of where the gastroscope landscape is moving and why. By clarifying key drivers and implications, the following sections provide a strategic foundation for investment prioritization, product development roadmaps, and commercial planning.

A clear synthesis of technological advances, evolving procurement priorities, regulatory emphasis on infection prevention, and digital integration shaping gastroscope adoption

The gastroscope landscape is experiencing a confluence of technological and operational shifts that are transforming clinical pathways and commercial models. High-definition digital imaging and the proliferation of video-based flexible endoscopes have raised diagnostic expectations, while advances in single-use components and sterilization science are reshaping infection control protocols. Concurrently, artificial intelligence tools for lesion detection and image enhancement are moving from pilot studies to routine clinical support, altering both procedural efficiency and clinician training requirements.

In parallel, changing procurement priorities emphasize lifecycle cost, consumables management, and bundled service agreements rather than upfront capital price alone. This shift encourages manufacturers to offer comprehensive service ecosystems that include professional education, remote diagnostics, and data analytics. Moreover, regulatory scrutiny on cross-contamination and environmental impact is prompting renewed attention to reusable device reprocessing pathways and the lifecycle implications of single-use alternatives. Taken together, these transformative shifts create new competitive spaces for companies that can integrate imaging excellence, digital services, and robust clinical evidence into compelling value propositions.

A nuanced analysis of how 2025 tariff recalibrations alter procurement economics, supplier strategies, and regional manufacturing decisions for gastroscope supply chains

Recent tariff adjustments have created a material reframing of global supply chain economics for advanced medical devices and associated consumables. Import tariffs increase landed costs for manufacturers and distributors that rely on cross-border component flows, prompting many organizations to reassess sourcing footprints and supplier diversification. As a result, procurement teams in hospitals and ambulatory settings are placing renewed emphasis on supplier resilience, dual sourcing, and localized inventory buffers to mitigate delivery risk and maintain continuity of care.

Moreover, tariffs encourage strategic shifts in manufacturing investment decisions. Some producers evaluate nearshoring or regional assembly to reduce exposure to trade friction, while others pursue long-term supplier contracts with price stabilization mechanisms. In turn, these adaptations affect channel strategy, with distributors and direct-sales organizations renegotiating commercial terms to preserve margins and service levels. Clinicians and purchasing stakeholders should therefore expect ongoing adjustments in product available configurations, lead times, and pricing conversations as companies balance cost absorption with competitive positioning.

Segment-driven insights that articulate product, end-user, application, and distribution dynamics to inform targeted commercial and clinical strategies

Segmentation analysis reveals differentiated value levers across product types, end-user profiles, clinical applications, and distribution channels. Within product segmentation, flexible and rigid gastroscopes address distinct clinical needs: flexible devices provide access and maneuverability essential for diagnostic and therapeutic workflows, whereas rigid instruments are adopted in specific procedural contexts with different sterilization and reprocessing profiles. The flexible category itself divides into fiberoptic and video technologies, with video systems offering superior imaging, digital integration, and easier incorporation of image analysis tools. Conversely, rigid devices may appear as reusable platforms optimized for durability and cost per procedure, or as single-use disposables that reduce cross-contamination risk and simplify logistics.

End-user segmentation highlights divergent purchasing criteria among ambulatory surgical centers, clinics, and hospitals. Ambulatory surgical centers often prioritize throughput, lower per-procedure costs, and streamlined sterilization, which can favor single-use approaches or compact, service-light systems. Clinics may emphasize diagnostic performance and capital efficiency, seeking versatile platforms that support a range of applications in limited space. Hospitals typically demand enterprise-grade interoperability, service contracts, and solutions that integrate with broader imaging and electronic health record systems.

Application segmentation further clarifies clinical requirements, where combined procedures require modular instruments and flexible platforms that support diagnostic inspection followed by therapeutic intervention. Diagnostic-focused workflows emphasize image clarity, reproducibility, and documentation features, while therapeutic use demands robust working channels, instrument compatibility, and device durability. Distribution channel segmentation rounds out the picture by differentiating direct sales, distributors, and online channel strategies. Direct sales often deliver deep clinical engagement and integrated service offerings, distributors provide regional reach and inventory management, and online channels facilitate rapid procurement of consumables and single-use products. Each distribution pathway influences customer experience, lead times, and the degree of clinical support available post-sale.

An evidence-based regional comparison of clinical adoption drivers, reimbursement patterns, and manufacturing dynamics across key global markets

Regional variations in clinical practice, reimbursement frameworks, and manufacturing ecosystems meaningfully influence adoption patterns and strategic priorities. In the Americas, mature clinical infrastructures and concentrated purchasing networks create opportunities for premium imaging platforms and integrated service agreements, while also motivating investment in localized manufacturing or assembly to reduce tariff exposure and speed time-to-market. As a result, stakeholder dialogues in this region often center on total cost of ownership, interoperability with hospital systems, and the evidence base needed to support adoption.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory complexity and wide variance in healthcare funding shape procurement behavior. In parts of this region, stringent reprocessing standards and centralized purchasing mechanisms encourage durable, reusable systems with comprehensive service offerings. Elsewhere, constrained budgets and the need for rapid deployment drive interest in cost-effective single-use alternatives and online procurement channels. These contrasting incentives require manufacturers to adopt flexible commercial models and region-specific evidence generation strategies.

Asia-Pacific is characterized by rapid capacity expansion, growing procedural volumes, and a mix of domestic manufacturing capabilities alongside multinational investment. Strong demand in this region accelerates adoption of digital imaging and telemedicine-enabled workflows, while regional manufacturing hubs create competitive opportunities for cost-efficient production. Consequently, companies operating in Asia-Pacific must balance innovation with affordability and prioritize partnerships that enhance distribution reach and regulatory navigation.

An incisive appraisal of competitive tactics showing how product innovation, services, and channel strategies are redefining vendor positioning in the gastroscope market

Leading companies in the gastroscope ecosystem are differentiating through innovation in imaging, disposables strategy, and service delivery. Many established manufacturers prioritize high-resolution video systems and modular architectures that facilitate clinical upgrades without full platform replacement. At the same time, a growing set of contenders emphasizes single-use gastroscopes and hybrid service models to address infection control concerns and reduce reprocessing burdens for facilities with constrained sterile processing capacity.

Strategic activity often centers on deepening clinical partnerships, investing in post-market clinical studies, and bundling digital services such as remote diagnostics, predictive maintenance, and outcome tracking. In addition, several players pursue vertical integration across consumables and capital equipment to secure recurring revenue streams and tighten customer relationships. Distribution strategies also vary, with some companies strengthening direct sales forces to support complex institutional procurements, while others expand distributor networks or online platforms to accelerate consumable turnover and reach decentralized provider segments.

Actionable strategic recommendations for manufacturers, providers, and channel partners to convert structural change into durable competitive advantage

Industry leaders can convert market complexity into competitive advantage by aligning product roadmaps with clinical workflows and procurement realities. Manufacturers should prioritize interoperability and modularity to protect customer investments while enabling iterative upgrades that incorporate enhanced imaging and AI capabilities. Simultaneously, investing in robust clinical evidence and real-world outcome tracking will accelerate adoption by demonstrating tangible improvements in diagnostic accuracy and procedural efficiency.

From a supply perspective, diversifying sourcing and evaluating regional manufacturing partnerships will reduce exposure to trade disruptions and tariff volatility. Companies should also design flexible commercial models that accommodate direct hospital procurement, distributor relationships, and online consumable channels to match end-user preferences. For clinical and operational leaders, adopting a lifecycle lens that examines total cost, reprocessing complexity, and clinical throughput will yield better purchasing decisions. Finally, cross-sector collaboration-between device makers, health systems, and payers-can create bundled service offerings that align incentives around improved patient outcomes and predictable cost structures.

A rigorous mixed-methods research framework combining primary stakeholder interviews, regulatory and clinical evidence review, and supply chain analysis to underpin the findings

This research follows a mixed-methods approach that integrates primary stakeholder engagement with secondary evidence triangulation to ensure robust, reproducible insights. Primary inputs include structured interviews with clinical leaders, procurement specialists, device engineers, and distribution executives, supplemented by advisory panels that validate emerging themes and operational priorities. These engagements provide real-world context for clinical workflows, decision criteria, and the practical constraints that shape purchasing cycles.

Secondary analysis draws on regulatory filings, clinical trial registries, patent landscapes, and peer-reviewed clinical literature to map technological maturity and safety evidence. Supply chain mapping and trade flow analysis illuminate sourcing concentrations and vulnerability points, while usability and lifecycle assessments inform discussions about reprocessing and single-use trade-offs. All findings undergo cross-validation through iterative analyst review and expert feedback to reduce bias and improve applicability for strategic planning.

A concise synthesis of strategic imperatives and forward-looking priorities that crystalize the path to safer, more efficient gastroscopy solutions

In summary, the gastroscope landscape is simultaneously conserved in its clinical purpose and dynamic in its commercial and technological expression. Diagnostic clarity, infection-control imperatives, and evolving procurement priorities are converging to reshape product design, distribution, and service models. Strategic responses now revolve around integrating advanced imaging and data capabilities, offering flexible commercial terms, and reinforcing supply chain resilience in the face of tariff and trade uncertainty.

Looking ahead, organizations that align product innovation with demonstrable clinical value and that adopt adaptable manufacturing and go-to-market strategies will be best positioned to capture growth opportunities. Collaboration across clinical, regulatory, and commercial stakeholders will accelerate adoption of safer, more efficient gastroscopy solutions that meet the twin demands of performance and sustainability. The analysis provided here offers a foundation for strategic choices that prioritize patient outcomes while managing operational and economic risk.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroscopes Market, by Product

  • 8.1. Flexible
    • 8.1.1. Fiberoptic
    • 8.1.2. Video
  • 8.2. Rigid
    • 8.2.1. Reusable
    • 8.2.2. Single Use

9. Gastroscopes Market, by Distribution Channel

  • 9.1. Offline
  • 9.2. Online

10. Gastroscopes Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Gastroscopes Market, by Application

  • 11.1. Combined
  • 11.2. Diagnostic
  • 11.3. Therapeutic

12. Gastroscopes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastroscopes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastroscopes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gastroscopes Market

16. China Gastroscopes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ambu A/S
  • 17.6. Ankon Medical Technologies Co., Ltd.
  • 17.7. Aohua Endoscopy Co., Ltd.
  • 17.8. B. Braun Melsungen AG
  • 17.9. Becton, Dickinson and Company
  • 17.10. Boston Scientific Corporation
  • 17.11. CONMED Corporation
  • 17.12. Cook Medical LLC
  • 17.13. Ethicon
  • 17.14. Fujifilm Holdings Corporation
  • 17.15. KARL STORZ SE & Co. KG
  • 17.16. Medtronic plc
  • 17.17. Mindray Bio-Medical Electronics Co., Ltd.
  • 17.18. Olympus Corporation
  • 17.19. PENTAX Medical
  • 17.20. Richard Wolf GmbH
  • 17.21. Smith & Nephew plc
  • 17.22. SonoScape Medical Corp.
  • 17.23. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROSCOPES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROSCOPES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROSCOPES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROSCOPES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROSCOPES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROSCOPES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROSCOPES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROSCOPES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROSCOPES MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROSCOPES MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROSCOPES MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROSCOPES MARKET SIZE, BY FIBEROPTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROSCOPES MARKET SIZE, BY FIBEROPTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROSCOPES MARKET SIZE, BY FIBEROPTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROSCOPES MARKET SIZE, BY VIDEO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROSCOPES MARKET SIZE, BY VIDEO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROSCOPES MARKET SIZE, BY VIDEO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROSCOPES MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROSCOPES MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROSCOPES MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROSCOPES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROSCOPES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROSCOPES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROSCOPES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROSCOPES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROSCOPES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROSCOPES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROSCOPES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROSCOPES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROSCOPES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROSCOPES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROSCOPES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROSCOPES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROSCOPES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROSCOPES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROSCOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROSCOPES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROSCOPES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROSCOPES MARKET SIZE, BY COMBINED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROSCOPES MARKET SIZE, BY COMBINED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROSCOPES MARKET SIZE, BY COMBINED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROSCOPES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROSCOPES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROSCOPES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROSCOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROSCOPES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROSCOPES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS GASTROSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. GCC GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GCC GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 117. GCC GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 119. GCC GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. GCC GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GCC GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. G7 GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. G7 GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 138. G7 GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 139. G7 GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 140. G7 GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. G7 GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. G7 GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. NATO GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. NATO GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 146. NATO GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 147. NATO GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. NATO GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. NATO GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)